Shine and Lal Index Calculator
Calculate the Shine and Lal Index using mean corpuscular volume and mean corpuscular hemoglobin to help distinguish a thalassemia trait pattern from an iron deficiency pattern in patients with microcytosis.
--
What is the Shine and Lal Index?
The Shine and Lal Index is a red blood cell discrimination index that uses the mean corpuscular volume and mean corpuscular hemoglobin obtained from the complete blood count.
It was developed as a screening approach to help differentiate iron deficiency anemia from beta thalassemia trait in patients with microcytosis.
A lower Shine and Lal Index is traditionally associated with a thalassemia trait pattern, whereas a higher value is more consistent with an iron deficiency pattern.
The index is intended for screening and should always be interpreted together with the complete blood count, iron studies, peripheral smear and appropriate hemoglobin analysis.
Shine and Lal Index Interpretation
| Shine and Lal Index | Screening Pattern | Clinical Consideration |
|---|---|---|
| Less than 1530 | Thalassemia trait pattern | Consider thalassemia trait when supported by the CBC and clinical setting. |
| Around 1530 | Borderline or indeterminate | The index alone may not reliably distinguish iron deficiency from thalassemia trait. |
| 1530 or higher | Iron deficiency pattern | Iron deficiency should be considered, especially when supported by ferritin and other iron studies. |
The threshold of 1530 is a commonly used screening convention. Diagnostic performance can vary between populations and clinical settings.
CBC Findings in Iron Deficiency and Thalassemia Trait
| Parameter | Iron Deficiency Pattern | Thalassemia Trait Pattern |
|---|---|---|
| MCV | Often decreased | Often markedly decreased |
| MCH | Often decreased | Often decreased |
| RBC count | Often low or normal | Often relatively preserved or increased |
| RDW | Often increased | Often normal or mildly increased |
| Ferritin | Often decreased | Usually normal |
| Hemoglobin analysis | Usually not diagnostic | May support diagnosis depending on the type |
What Should Be Considered After a Low Shine and Lal Index?
A low Shine and Lal Index may suggest a thalassemia trait pattern, but it does not establish the diagnosis.
Evaluation may include serum ferritin, serum iron, transferrin saturation, peripheral blood smear and hemoglobin analysis depending on the clinical setting.
If thalassemia remains suspected despite a non-diagnostic hemoglobin analysis, molecular testing may be considered in selected patients, particularly when alpha thalassemia is suspected.
Shine and Lal Index Calculator - Frequently Asked Questions
What is the Shine and Lal Index formula?
The Shine and Lal Index is calculated as MCV multiplied by MCV multiplied by MCH, divided by 100.
What does a value below 1530 mean?
A value below 1530 is traditionally associated with a thalassemia trait pattern. It is a screening result and not a definitive diagnosis.
What does a value of 1530 or higher mean?
A value of 1530 or higher is traditionally more consistent with an iron deficiency pattern.
Can the Shine and Lal Index diagnose thalassemia?
No. The index is a screening and discrimination tool. Diagnosis may require hemoglobin analysis, clinical assessment and, in selected cases, molecular testing.
Why are MCV and MCH used?
Both MCV and MCH reflect red blood cell size and hemoglobin content and can change substantially in microcytic disorders.
Should ferritin be checked?
Yes. When iron deficiency is suspected, ferritin and other iron studies generally provide more direct evidence of iron status than a discrimination index.
Medical Disclaimer: This calculator is intended for educational and clinical reference purposes. The Shine and Lal Index is a screening and discrimination index and should not be used as a standalone diagnostic test for iron deficiency or thalassemia. Interpretation should consider the complete CBC, peripheral smear, ferritin, iron studies, clinical history and, when appropriate, hemoglobin analysis or molecular testing. Reference thresholds and diagnostic performance may vary among populations and clinical settings.
0 Comments